Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease

被引:9
|
作者
Zhou, Liangliang [1 ,2 ]
Shen, Haiyuan [1 ,2 ]
Li, Xiaofeng [2 ,3 ]
Wang, Hua [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
[2] Anhui Med Univ, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China
[3] Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Hefei, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
non-alcoholic fatty liver disease; immune cells; unfolded protein response; endoplasmic reticulum stress; hepatic steatosis; UNFOLDED-PROTEIN-RESPONSE; LIFE-STYLE MODIFICATION; KILLER T-CELLS; ER STRESS; DENDRITIC CELLS; TRANSCRIPTION FACTOR; LIPID-METABOLISM; MACROPHAGE APOPTOSIS; DEFICIENCY PROTECTS; HEPATIC STEATOSIS;
D O I
10.3389/fimmu.2022.951406
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liver disease and its complications affect millions of people worldwide. NAFLD (non-alcoholic fatty liver disease) is the liver disease associated with metabolic dysfunction and consists of four stages: steatosis with or without mild inflammation (NAFLD), non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. With increased necroinflammation and progression of liver fibrosis, NAFLD may progress to cirrhosis or even hepatocellular carcinoma. Although the underlying mechanisms have not been clearly elucidated in detail, what is clear is that complex immune responses are involved in the pathogenesis of NASH, activation of the innate immune system is critically involved in triggering and amplifying hepatic inflammation and fibrosis in NAFLD/NASH. Additionally, disruption of endoplasmic reticulum (ER) homeostasis in cells, also known as ER stress, triggers the unfolded protein response (UPR) which has been shown to be involved to inflammation and apoptosis. To further develop the prevention and treatment of NAFLD/NASH, it is imperative to clarify the relationship between NAFLD/NASH and innate immune cells and ER stress. As such, this review focuses on innate immune cells and their ER stress in the occurrence of NAFLD and the progression of cirrhosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Chronic Treatment with Low Doses of Resveratrol Improves Non-Alcoholic Fatty Liver Disease by Modulating Endoplasmic Reticulum Stress Related Factors
    Rojas, Cristina
    Valls, Cristina
    Pujadas, Gerard
    Garcia-Vallve, Santi
    Mulero, Miquel
    ANNALS OF NUTRITION AND METABOLISM, 2013, 62 : 62 - 62
  • [32] Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model
    Hosseini, Seyedeh Parisa
    Farivar, Shirin
    Rezaei, Ramazan
    Tokhanbigli, Samaneh
    Hatami, Behzad
    Zali, Mohammad Reza
    Baghaei, Kaveh
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 31 (01) : 29 - 37
  • [33] Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model
    Seyedeh Parisa Hosseini
    Shirin Farivar
    Ramazan Rezaei
    Samaneh Tokhanbigli
    Behzad Hatami
    Mohammad Reza Zali
    Kaveh Baghaei
    DARU Journal of Pharmaceutical Sciences, 2023, 31 : 29 - 37
  • [34] Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease
    Na, Man
    Yang, Xingbiao
    Deng, Yongkun
    Yin, Zhaoheng
    Li, Mingwei
    PEERJ, 2023, 11
  • [35] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [36] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [37] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [38] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [39] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [40] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377